Immunarray: ImmunArray Receives Exclusive License to New U.S. Patent

Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray a molecular diagnostic company coheadquartered in Rehovot Israel and Richmond Virginia whose novel blood tests are pioneering new and more accurate ways to diagnose dis...